Knowledge Home Human Health Knowledge All Opinion Papers Popular science Interviews Filter Therapeutic areasCOVID-19Digestive health Apply Home Human Health Knowledge Test of Safety and immunogenicity of a PHH-1V booster dose after different prime vaccination schemes against COVID-19: Phase III clinical trial final results up to one year Home Human Health Knowledge Test Human Knowledge ENN Home Human Health Knowledge Safety and immunogenicity of a PHH-1V booster dose after different prime vaccination schemes against COVID-19: Phase III clinical trial final results up to one year Home Human Health Knowledge Immunogenicity and safety of an Omicron XBB.1.16 adapted vaccine for COVID-19: Interim results from a randomized, controlled, non-inferiority clinical trial Home Human Health Knowledge Safety and immunogenicity of PHH-1V as booster vaccination through the Omicron era: results from a phase IIb open-label extension study up to 6 months Home Human Health Knowledge Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial Home Human Health Knowledge Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 Home Human Health Knowledge Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Home Human Health Knowledge Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates Load more
